These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 12115542
1. Retinoic acid modulates the ability of macrophages to participate in the induction of the angiogenic phenotype in head and neck squamous cell carcinoma. Liss C, Fekete MJ, Hasina R, Lingen MW. Int J Cancer; 2002 Jul 20; 100(3):283-9. PubMed ID: 12115542 [Abstract] [Full Text] [Related]
2. Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages. Liss C, Fekete MJ, Hasina R, Lam CD, Lingen MW. Int J Cancer; 2001 Sep 20; 93(6):781-5. PubMed ID: 11519037 [Abstract] [Full Text] [Related]
3. [Antiangiogenic and anti-immunosuppressive therapeutic strategies in human head and neck squamous cell carcinoma (HNSCC)]. Strauss L, Volland D, Guerrero A, Reichert T. Mund Kiefer Gesichtschir; 2005 Sep 20; 9(5):273-81. PubMed ID: 16096774 [Abstract] [Full Text] [Related]
4. Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma. Lingen MW, Polverini PJ, Bouck NP. Cancer Res; 1998 Dec 01; 58(23):5551-8. PubMed ID: 9850093 [Abstract] [Full Text] [Related]
5. Regulation of the steps of angiogenesis by human head and neck squamous cell carcinomas. Benefield J, Petruzzelli GJ, Fowler S, Taitz A, Kalkanis J, Young MR. Invasion Metastasis; 1996 Dec 01; 16(6):291-301. PubMed ID: 9371228 [Abstract] [Full Text] [Related]
6. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. Salven P, Heikkilä P, Anttonen A, Kajanti M, Joensuu H. Mod Pathol; 1997 Nov 01; 10(11):1128-33. PubMed ID: 9388064 [Abstract] [Full Text] [Related]
7. Inhibition of squamous cell carcinoma angiogenesis by direct interaction of retinoic acid with endothelial cells. Lingen MW, Polverini PJ, Bouck NP. Lab Invest; 1996 Feb 01; 74(2):476-83. PubMed ID: 8780165 [Abstract] [Full Text] [Related]
8. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Dong G, Chen Z, Li ZY, Yeh NT, Bancroft CC, Van Waes C. Cancer Res; 2001 Aug 01; 61(15):5911-8. PubMed ID: 11479233 [Abstract] [Full Text] [Related]
16. Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma. Masuda M, Ruan HY, Ito A, Nakashima T, Toh S, Wakasaki T, Yasumatsu R, Kutratomi Y, Komune S, Weinstein IB. Oral Oncol; 2007 Sep 01; 43(8):785-90. PubMed ID: 17169602 [Abstract] [Full Text] [Related]
17. Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma. Lalla RV, Boisoneau DS, Spiro JD, Kreutzer DL. Arch Otolaryngol Head Neck Surg; 2003 Aug 01; 129(8):882-8. PubMed ID: 12925349 [Abstract] [Full Text] [Related]
18. Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance. Strauss L, Volland D, Kunkel M, Reichert TE. Med Sci Monit; 2005 Aug 01; 11(8):BR280-92. PubMed ID: 16049374 [Abstract] [Full Text] [Related]
19. Role of angiogenic factors: coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma. Eisma RJ, Spiro JD, Kreutzer DL. Laryngoscope; 1999 May 01; 109(5):687-93. PubMed ID: 10334214 [Abstract] [Full Text] [Related]
20. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration. Riedel F, Götte K, Li M, Hörmann K, Grandis JR. Int J Oncol; 2002 Jul 01; 21(1):11-6. PubMed ID: 12063543 [Abstract] [Full Text] [Related] Page: [Next] [New Search]